162 related articles for article (PubMed ID: 32571290)
1. Multiple primary tumors: a case report and review of the literature.
Zhao Z; Sun K; Yan T; Wei R; Guo W
BMC Musculoskelet Disord; 2020 Jun; 21(1):394. PubMed ID: 32571290
[TBL] [Abstract][Full Text] [Related]
2. An extremely rare case of primary malignancy in giant cell tumor of bone, arising in the right femur and harboring H3F3A mutation.
Tsukamoto Y; Futani H; Kihara T; Watanabe T; Kumanishi S; Matsuo S; Hirota S; Ueda T; Yamamoto H; Yoshiya S
Pathol Res Pract; 2018 Sep; 214(9):1504-1509. PubMed ID: 29970305
[TBL] [Abstract][Full Text] [Related]
3. Malignant fibrous histiocytoma and osteosarcoma in association with fibrous dysplasia of bone. Report of three cases.
Ishida T; Machinami R; Kojima T; Kikuchi F
Pathol Res Pract; 1992 Aug; 188(6):757-63. PubMed ID: 1332006
[TBL] [Abstract][Full Text] [Related]
4. Histone 3.3 mutations in giant cell tumor and giant cell-rich sarcomas of bone.
Righi A; Mancini I; Gambarotti M; Picci P; Gamberi G; Marraccini C; Dei Tos AP; Simi L; Pinzani P; Franchi A
Hum Pathol; 2017 Oct; 68():128-135. PubMed ID: 28899740
[TBL] [Abstract][Full Text] [Related]
5. Giant-cell-poor giant cell tumor of bone: report of two cases and literature review.
Yakoub MA; Torrence D; Hwang S; Bartelstein M; Healey JH; Hameed M
Skeletal Radiol; 2023 Sep; 52(9):1791-1798. PubMed ID: 36781420
[TBL] [Abstract][Full Text] [Related]
6. Receptor-Activator of Nuclear KappaB Ligand Expression as a New Therapeutic Target in Primary Bone Tumors.
Yamagishi T; Kawashima H; Ogose A; Ariizumi T; Sasaki T; Hatano H; Hotta T; Endo N
PLoS One; 2016; 11(5):e0154680. PubMed ID: 27163152
[TBL] [Abstract][Full Text] [Related]
7. H3F3A (Histone 3.3) G34W Immunohistochemistry: A Reliable Marker Defining Benign and Malignant Giant Cell Tumor of Bone.
Amary F; Berisha F; Ye H; Gupta M; Gutteridge A; Baumhoer D; Gibbons R; Tirabosco R; O'Donnell P; Flanagan AM
Am J Surg Pathol; 2017 Aug; 41(8):1059-1068. PubMed ID: 28505000
[TBL] [Abstract][Full Text] [Related]
8. Association of Metastasis with Clinicopathological Data in Mexican Patients with Osteosarcoma, Giant Cell Tumor of Bone and Chondrosarcoma.
Estrada-Villaseor E; Escamilla-Uribe R; De la Garza-Montano P; Dominguez-Rubio R; Martinez-Lopez V; Avila-Luna A; Alfaro-Rodriguez A; Ruvalcaba-Paredes EK; Garciadiego-Cazares D; Bandala C
Asian Pac J Cancer Prev; 2015; 16(17):7689-94. PubMed ID: 26625782
[TBL] [Abstract][Full Text] [Related]
9. Rapidly growing giant cell tumor of bone in a skeletally immature girl.
Akaike G; Ueno T; Matsumoto S; Motoi N; Matsueda K
Skeletal Radiol; 2016 Apr; 45(4):567-73. PubMed ID: 26585568
[TBL] [Abstract][Full Text] [Related]
10. Development of high-grade osteosarcoma in a patient with recurrent giant cell tumor of the ischium while receiving treatment with denosumab.
Tsukamoto S; Righi A; Vanel D; Honoki K; Donati DM; Errani C
Jpn J Clin Oncol; 2017 Nov; 47(11):1090-1096. PubMed ID: 29048579
[TBL] [Abstract][Full Text] [Related]
11. Knock-down of oncohistone H3F3A-G34W counteracts the neoplastic phenotype of giant cell tumor of bone derived stromal cells.
Fellenberg J; Sähr H; Mancarella D; Plass C; Lindroth AM; Westhauser F; Lehner B; Ewerbeck V
Cancer Lett; 2019 Apr; 448():61-69. PubMed ID: 30742944
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic utility of histone H3.3 G34W, G34R, and G34V mutant-specific antibodies for giant cell tumors of bone.
Yamamoto H; Iwasaki T; Yamada Y; Matsumoto Y; Otsuka H; Yoshimoto M; Kohashi K; Taguchi K; Yokoyama R; Nakashima Y; Oda Y
Hum Pathol; 2018 Mar; 73():41-50. PubMed ID: 29241742
[TBL] [Abstract][Full Text] [Related]
13. Symplastic/pseudoanaplastic giant cell tumor of the bone.
Sarungbam J; Agaram N; Hwang S; Lu C; Wang L; Healey J; Hameed M
Skeletal Radiol; 2016 Jul; 45(7):929-35. PubMed ID: 27020452
[TBL] [Abstract][Full Text] [Related]
14. [H3F3A mutated multicentric giant cell tumor of bone : A very rare primary bone disease].
Giesche JP; von Baer A; Breining T; Marienfeld R; Mellert K; Lüke J; Schultheiss M; Möller P; Barth TFE
Pathologe; 2018 Sep; 39(5):451-456. PubMed ID: 30046846
[TBL] [Abstract][Full Text] [Related]
15. Primary malignancy in giant cell tumor: a case report.
Bispo Júnior RZ; Camargo OP; Ida CM; Baptista AM; Ribeiro MB; Bruno JM; Oliveira CR
Sao Paulo Med J; 2009 Sep; 127(5):310-3. PubMed ID: 20169281
[TBL] [Abstract][Full Text] [Related]
16. Case report 863. Osteosarcoma associated with giant cell tumor.
Kenan S; Abdelwahab IF; Klein MJ; Lewis MM
Skeletal Radiol; 1995 Jan; 24(1):55-8. PubMed ID: 7709255
[No Abstract] [Full Text] [Related]
17. Malignant Transformation of Giant Cell Tumor of Bone 7 years After Initial Surgery: A Case Report and Literature Review.
Matsunobu T; Maekawa A; Jotatsu M; Makihara K; Hisaoka M; Iwamoto Y
JBJS Case Connect; 2021 Apr; 11(2):. PubMed ID: 33878040
[TBL] [Abstract][Full Text] [Related]
18. Epidemiological Aspects of Osteosarcoma, Giant Cell Tumor and Chondrosarcoma Musculoskeletal Tumors--Experience of the National Rehabilitation Institute, Mexico City.
DelaGarza-Montano P; Estrada-Villasenor E; Dominguez Rubio R; Martinez-Lopez V; Avila-Luna A; Alfaro-Rodriguez A; Garciadiego-Cazares D; Carlos A; Hernandez-Perez AD; Bandala C
Asian Pac J Cancer Prev; 2015; 16(15):6451-5. PubMed ID: 26434858
[TBL] [Abstract][Full Text] [Related]
19. Giant cell tumours of bone treated with denosumab: histological, immunohistochemical and H3F3A mutation analyses.
Kato I; Furuya M; Matsuo K; Kawabata Y; Tanaka R; Ohashi K
Histopathology; 2018 May; 72(6):914-922. PubMed ID: 29206281
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic value of histone 3 mutations in osteoclast-rich bone tumors.
Nohr E; Lee LH; Cates JM; Perizzolo M; Itani D
Hum Pathol; 2017 Oct; 68():119-127. PubMed ID: 28882701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
